報價延遲最少15分鐘:2025/03/28 08:23 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
7.39 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.11/0.22
|
|
企業價值
596.45M
|
| 資產負債 |
|
每股賬面淨值
0.59
|
| 現金流量 |
|
現金流量率
0.02
|
| 損益表 |
|
收益
99.60M
|
|
每股收益
1.07
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/03/28 08:23 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands. |